» Articles » PMID: 23874682

Microbial Reprogramming Inhibits Western Diet-associated Obesity

Abstract

A recent epidemiological study showed that eating 'fast food' items such as potato chips increased likelihood of obesity, whereas eating yogurt prevented age-associated weight gain in humans. It was demonstrated previously in animal models of obesity that the immune system plays a critical role in this process. Here we examined human subjects and mouse models consuming Westernized 'fast food' diet, and found CD4(+) T helper (Th)17-biased immunity and changes in microbial communities and abdominal fat with obesity after eating the Western chow. In striking contrast, eating probiotic yogurt together with Western chow inhibited age-associated weight gain. We went on to test whether a bacteria found in yogurt may serve to lessen fat pathology by using purified Lactobacillus reuteri ATCC 6475 in drinking water. Surprisingly, we discovered that oral L. reuteri therapy alone was sufficient to change the pro-inflammatory immune cell profile and prevent abdominal fat pathology and age-associated weight gain in mice regardless of their baseline diet. These beneficial microbe effects were transferable into naïve recipient animals by purified CD4(+) T cells alone. Specifically, bacterial effects depended upon active immune tolerance by induction of Foxp3(+) regulatory T cells (Treg) and interleukin (Il)-10, without significantly changing the gut microbial ecology or reducing ad libitum caloric intake. Our finding that microbial targeting restored CD4(+) T cell balance and yielded significantly leaner animals regardless of their dietary 'fast food' indiscretions suggests population-based approaches for weight management and enhancing public health in industrialized societies.

Citing Articles

Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome.

Denys M, Kozlova E, Liu R, Bishay A, Do E, Piamthai V Arch Toxicol. 2024; 99(1):423-446.

PMID: 39520540 PMC: 11748483. DOI: 10.1007/s00204-024-03882-4.


The gut microbiome and sociability.

Weber K, Varian B, Erdman S Front Neurosci. 2024; 18:1372274.

PMID: 38629051 PMC: 11018908. DOI: 10.3389/fnins.2024.1372274.


The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential.

Avtanski D, Reddy V, Stojchevski R, Hadzi-Petrushev N, Mladenov M Pathogens. 2023; 12(12).

PMID: 38133287 PMC: 10747404. DOI: 10.3390/pathogens12121402.


Brain trust.

Erdman S Compr Psychoneuroendocrinol. 2023; 16:100212.

PMID: 38108028 PMC: 10724819. DOI: 10.1016/j.cpnec.2023.100212.


Oxytocin and the microbiome.

Varian B, Weber K, Erdman S Compr Psychoneuroendocrinol. 2023; 16:100205.

PMID: 38108027 PMC: 10724733. DOI: 10.1016/j.cpnec.2023.100205.


References
1.
Chaudhry A, Samstein R, Treuting P, Liang Y, Pils M, Heinrich J . Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011; 34(4):566-78. PMC: 3088485. DOI: 10.1016/j.immuni.2011.03.018. View

2.
Sakaguchi S, Miyara M, Costantino C, Hafler D . FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010; 10(7):490-500. DOI: 10.1038/nri2785. View

3.
Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow?. Lancet. 2001; 357(9255):539-45. DOI: 10.1016/S0140-6736(00)04046-0. View

4.
Berer K, Mues M, Koutrolos M, Al Rasbi Z, Boziki M, Johner C . Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011; 479(7374):538-41. DOI: 10.1038/nature10554. View

5.
Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P . Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond). 2011; 36(6):817-25. PMC: 3374072. DOI: 10.1038/ijo.2011.153. View